Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Update on Eloxatin (oxaliplatin) U.S. Patent Litigation
Sanofi-aventis, 06/19/09
Sanofi-aventis has learned that the U.S. District Court for the District of New Jersey has ruled against the Group by granting summary judgment motions brought by certain generic companies in the U.S. Eloxatin patent litigation. Sanofi-aventis intends to appeal this decision.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Article Search
Sponsor